http://library.northernlight.com/HC20020107390000016.html?cb=0&dx=2006&sc=0#doc
|
|
|
|
||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||
![]()
CDC Tests Blood as Possible Anthrax Treatment
Story Filed: Monday,
January 07, 2002 10:10 PM EST
WASHINGTON (Reuters) -
Blood taken from servicemen and women who have been vaccinated against anthrax
may be filtered and used as a treatment in any future anthrax cases, a federal
health official said on Monday.
The blood of vaccinated
people contains antibodies that can counteract the deadly toxin made by the
anthrax bacteria, said Dr. Brad Perkins, an anthrax expert at the Centers for
Disease Control and Prevention (CDC).
The issue has taken on new
urgency after a series of mailed anthrax attacks that have killed five people
and made 13 others sick since Oct. 4, Perkins told a meeting of the Institute
of Medicine's committee on anthrax vaccine safety.
He said the U.S. Food and
Drug Administration (FDA) was deciding whether to let CDC test ways to use the
blood as a treatment.
Half a million U.S.
servicemen and women have been vaccinated against anthrax, starting with the
1991 Gulf War when it was feared anthrax might be used as a weapon.
Vaccination stopped after
problems with the production facilities, and although the vaccine is considered
safe, many who got it complained of side-effects. The CDC plans to survey the
military about attitudes toward the vaccine.
The CDC is also planning
new trials of the vaccine, to see if the current six-shot regimen can be reduced
to three shots and still provide protection.
The trial will also test
whether a less-painful method of injection, into the muscle instead of under
the skin, will work. Perkins said the CDC would seek 1,500 volunteers for the
study.
Perkins said CDC had taken
75 one-liter (one quart) units of serum from some of the vaccinated soldiers to
use in a range of tests. This included an assay that could be used to show if
someone who had been vaccinated was actually immune to anthrax.
``Now this becomes more
important on the civilian spectrum as well,'' Perkins told reporters. ``When we
started having cases in the United States we realized that we needed to be
prepared to use this as an adjunct to antibiotic therapy.''
Antibiotics can cure
anthrax, but if a person has the serious inhaled version of the disease, it can
be too late to treat it by the time symptoms show.
This is because the anthrax
bacteria pump toxins into the system. ``When you get enough toxin in your
system, you can kill all the bacteria that you want but it's the toxin that is
going to kill you,'' Perkins said.
``The antibodies allow us a
way to neutralize the toxin and that's why it is a good combination with the
antibiotics,'' Perkins added.
``We are taking serum from
people that have been vaccinated.
That serum has high levels
of antibody.''
The FDA must approve trials
of such a new approach, and Perkins said the agency has a draft proposal under
consideration now.
``If someone has
inhalational anthrax and they are doing poorly, we can get permission from the
FDA to use that to treat people,'' Perkins said. ``We could rush this through
if it was necessary.''
Other members of the panel
urged the CDC to move quickly.
``If I were a terrorist ...
I would be making a good anthrax spore preparation and I would be damned if I
would have any antibiotic-susceptible spores in there,'' Dr. Maurice Hilleman
told the meeting.
Taking antibiotics can
prevent infection even if a person breathes in anthrax spores or gets spores
into a cut in the skin.
Thousands of people exposed
to spores in the letter attacks took antibiotics for a recommended two months.
Some are still taking drugs and the CDC says just over 100 have taken up an
offer to get the vaccine -- which has been recommended in case spores are
lurking in their bodies.
Copyright © 2002 Reuters
Limited. All rights reserved. Republication or redistribution of Reuters
content, including by framing or similar means, is expressly prohibited without
the prior written consent of Reuters. Reuters and the dotted and sphere logos
are house marks of Reuters Limited. Reuters is a registered trade mark in more
than 25 countries worldwide.
You may now
print or save this document.
|
|
|||||||||
|
|
|
|
|
|
|||||
|
|
|||||||||
Portions of above Copyright © 1997-2001, Northern Light Technology,
LLC. All rights reserved.
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.